- Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium
- Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer
- Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US
- How Nefab’s Sustainable Packaging and Logistics Solutions Revolutionize the Healthcare Equipment Industry Supply Chain | By Lise-Anais Swiegot, Global Healthcare Segment Director with the Nefab Group
- Discover Reeva FT: Revolutionizing Wound Covering for Healthcare Pros
- Medical Grade, Premium Standing Solutions Drastically Improve Employee Comfort, Support, Productivity and Morale While Reducing Fatigue, Stress and Ailments | By Amy Hester, PhD, RN, BC, FAAN, Chairwoman and CEO, HD Nursing, & Daniel Bouzide, Founder and President, WellnessMats
- Unlocking New Hope: Alzheimer’s Patients Join Amyloid-Targeting Therapy Study
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States
Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. We take pride in offering high-quality, in-depth content, crafted by a team of experienced professionals. Our goal is to provide a unique perspective on the trends and innovations driving the future of medical technology. By reading our articles, you’re not only gaining exclusive industry insights but also becoming part of a community committed to advancing healthcare through groundbreaking technologies. Explore our content and consider partnering with us for advertising opportunities!
Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook
Clinical Trials
ACC.22: Medtronic Renal Denervation System Demonstrates Significant BP Reduction Through 3 Years
ACC.22: Medtronic adds to its robust clinical program with long-term data demonstrating the continued blood pressure lowering effect of the Symplicity renal denervation procedure. Also
completes enrollment in the SPYRAL HTN-ON MED trial.
Corvia Medical Reports: Reduce Lap-HF II Analyses Show 50% of Study Patients Demonstrated Significant Clinical Benefit from the Corvia Atrial Shunt
Corvia Medical notes in a large responder population, representing 50% of study patients, treatment with the Corvia® Atrial Shunt resulted in a 45% reduction in HF events and a 55% greater improvement in quality of life compared to sham control.
ReCor Medical Announces Completion of Enrollment in RADIANCE-II Pivotal Trial
ReCor Medical notes the data from RADIANCE-II will build on evidence from RADIANCE-HTN SOLO and TRIO studies to support pre-market application to the FDA
Biotechnology News
Our Experts – Byline Articles
Read Their Views & Share With a Colleague or Two!
Digital Pathology Reaches an Inflection Point as AI Targets Workflow Gaps | By Yair Rivenson, PhD Founder and CEO, Pictor Labs
Laboratories face mounting pressure to modernize imaging, preserve tissue, and reduce sequencing failures as adoption continues to move at a glacial pace
FIZE Medical Launches 5,000-Patient Retrospective Study to Further Establish the benefits of using FIZE kUO in managing ICU patients’ Hemodynamic status
By continuously capturing renal function patterns, the study aims to demonstrate how FIZE kUO® can provide data for early signs of instability that are often missed by intermittent measurements
Skin May Become the First Organ to Fulfill the Promise of Regenerative Medicine | By Dr. Ned Swanson – President & Chief Medical Officer of PolarityBio
The field of regenerative medicine may be on the cusp of an evolution, and due to the unique attributes of skin and wounds, the largest organ in the body may be emerging as a leader
FDA Medical Device Updates
Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding
Market Reports